Neuronetics (STIM) Revenue & Revenue Breakdown
Neuronetics Revenue Highlights
Latest Revenue (Y)
$71.35M
Latest Revenue (Q)
$16.45M
Neuronetics Revenue by Period
Neuronetics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $71.35M | 9.42% |
| 2022-12-31 | $65.21M | 17.89% |
| 2021-12-31 | $55.31M | 12.32% |
| 2020-12-31 | $49.24M | -21.41% |
| 2019-12-31 | $62.66M | 18.72% |
| 2018-12-31 | $52.78M | 30.53% |
| 2017-12-31 | $40.43M | 18.13% |
| 2016-12-31 | $34.23M | - |
Neuronetics generated $71.35M in revenue during NA 2023, up 9.42% compared to the previous quarter, and up 135.19% compared to the same period a year ago.
Neuronetics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $16.45M | -5.55% |
| 2024-03-31 | $17.42M | -14.26% |
| 2023-12-31 | $20.31M | 13.59% |
| 2023-09-30 | $17.88M | 1.56% |
| 2023-06-30 | $17.61M | 13.32% |
| 2023-03-31 | $15.54M | -14.61% |
| 2022-12-31 | $18.20M | 10.30% |
| 2022-09-30 | $16.50M | 1.03% |
| 2022-06-30 | $16.33M | 15.15% |
| 2022-03-31 | $14.18M | -5.60% |
| 2021-12-31 | $15.02M | 8.86% |
| 2021-09-30 | $13.80M | -2.84% |
| 2021-06-30 | $14.20M | 15.58% |
| 2021-03-31 | $12.29M | -21.12% |
| 2020-12-31 | $15.58M | 25.15% |
| 2020-09-30 | $12.45M | 27.79% |
| 2020-06-30 | $9.74M | -15.12% |
| 2020-03-31 | $11.48M | -33.88% |
| 2019-12-31 | $17.36M | 8.47% |
| 2019-09-30 | $16.00M | -3.45% |
| 2019-06-30 | $16.57M | 30.20% |
| 2019-03-31 | $12.73M | -18.59% |
| 2018-12-31 | $15.63M | 13.82% |
| 2018-09-30 | $13.74M | 3.66% |
| 2018-06-30 | $13.25M | 30.54% |
| 2018-03-31 | $10.15M | -16.15% |
| 2017-12-31 | $12.11M | 15.41% |
| 2017-09-30 | $10.49M | 1.78% |
| 2017-06-30 | $10.31M | 36.97% |
| 2017-03-31 | $7.53M | - |
Neuronetics generated $16.45M in revenue during Q2 2024, up -5.55% compared to the previous quarter, and up 105.86% compared to the same period a year ago.
Neuronetics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SHC | Sotera Health Company | $1.05B | $276.59M |
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| FONR | FONAR | $98.65M | $25.72M |
| STIM | Neuronetics | $71.35M | $16.45M |
| XGN | Exagen | $52.55M | $15.06M |
| BDSX | Biodesix | $49.09M | $14.82M |
| ENZ | Enzo Biochem | $31.06M | $8.02M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| SERA | Sera Prognostics | $306.00K | - |
STIM Revenue FAQ
What is Neuronetics’s yearly revenue?
Neuronetics's yearly revenue for 2023 was $71.35M, representing an increase of 9.42% compared to 2022. The company's yearly revenue for 2022 was $65.21M, representing an increase of 17.89% compared to 2021. STIM's yearly revenue for 2021 was $55.31M, representing an increase of 12.32% compared to 2020.
What is Neuronetics’s quarterly revenue?
Neuronetics's quarterly revenue for Q2 2024 was $16.45M, a -5.55% decrease from the previous quarter (Q1 2024), and a -6.59% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $17.42M, a -14.26% decrease from the previous quarter (Q4 2023), and a 12.08% increase year-over-year (Q1 2023). STIM's quarterly revenue for Q4 2023 was $20.31M, a 13.59% increase from the previous quarter (Q3 2023), and a 11.63% increase year-over-year (Q4 2022).
What is Neuronetics’s revenue growth rate?
Neuronetics's revenue growth rate for the last 3 years (2021-2023) was 28.99%, and for the last 5 years (2019-2023) was 13.87%.